Enocitabine

Product Name: Enocitabine
CAS No.: 55726-47-1
Chemical Name: Enocitabine
Synonyms: BH-AC;CS-1807;SUNRABIN;NSC-239336;ENOCITABINE;Enocitabine API;BEHENOYLCYTOSINE ARABINOSIDE;N4-Behenoylcytosine arabinoside;n(sup4)-behenoylcytosinearabinoside;ENOCITABINE 98.5+% ANTINEOPLASTIC DRUGS
CBNumber: CB3266605
Molecular Formula: C31H55N3O6
Formula Weight: 565.78
MOL File: 55726-47-1.mol

More

Less

Enocitabine Property

Melting point:: 141-142°C
alpha: D +70° (c = 1 in THF, 22°)
Boiling point:: 630.87°C (rough estimate)
Density: 1.0967 (rough estimate)
refractive index: 1.7800 (estimate)
storage temp.: Keep in dark place,Sealed in dry,Store in freezer, under -20°C
solubility: DMSO (Slightly, Heated), Methanol (Slightly, Heated), THF (Slightly, Heated, Soncited)
pka: 10.14±0.20(Predicted)
form: Solid
color: White to Off-White
CAS DataBase Reference: 55726-47-1(CAS DataBase Reference)

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

TRC

Product number: E557500
Product name: Enocitabine
Packaging: 10mg
Price: $90
Updated: 2021/12/16

Usbiological

Product number: 296092
Product name: Enocitabine
Packaging: 5mg
Price: $462
Updated: 2021/12/16

Biosynth Carbosynth

Product number: NE05152
Product name: Enocitabine
Packaging: 100mg
Price: $500
Updated: 2021/12/16

American Custom Chemicals Corporation

Product number: API0002546
Product name: ENOCITABINE
Purity: 95.00%
Packaging: 100MG
Price: $1593.9
Updated: 2021/12/16

ChemScene

Product number: CS-0082897
Product name: Enocitabine
Purity: ≥98.0%
Packaging: 10mg
Price: $680
Updated: 2021/12/16

More

Less

Enocitabine Chemical Properties,Usage,Production

Description

Enocitabine (NSC-239336, BHAC) is an antileukemic agent closely related to cytarabine. It appears more resistant to deamination than cytarabine, thus allowing greater in vivo phosphorylation into an active cytotoxic metabolite. Enocitabine is lipophilic, but the drug does not enter the cerebrospinal fluid and is concentrated in the bone marrow and red blood cells. It can be administered orally and appears to be more effective than the parent compound in preclinical models.

Chemical Properties

Crystalline Solid

Originator

Asahi (Japan)

Uses

An antineoplastic. A derivative of Cytarabine.

Definition

ChEBI: Enocitabine is an organic molecular entity.

brand name

SUNRABIN

Enocitabine Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Enocitabine Suppliers

Canada 1 China 62 Europe 2 India 1 United Kingdom 8 United States 22 Global 96

More

Less

View Lastest Price from Enocitabine manufacturers

Beijing Yibai Biotechnology Co., Ltd

Product: Enocitabine 55726-47-1
Price: US $0.00-0.00/KG
Min. Order: 1g
Purity: 99.0%
Supply Ability: 50kg/month
Release date: 2019-08-28

Career Henan Chemical Co

Product: Enocitabine 55726-47-1
Price: US $1.00/KG
Min. Order: 1IU
Purity: 99%
Supply Ability: 100kg
Release date: 2019-12-24

55726-47-1, EnocitabineRelated Search:

Enoxacin 5-Aza-2'-deoxycytidine Capecitabine Docosanoic acid Docosanamide 1,4-Dioxane Gemcitabine Enoxacin gluconate 2-HYDROXYACETAMIDE Pyrimidine Gemcitabine hydrochloride HEPARIN Cytarabine N-ALLYL STEARAMIDE N4-OCTADECYLCYTOSINE BETA-D-ARABINOFURANOSIDE Enocitabine ENOCITABINE

N-(1-BETA-D-ARABINOFURANOSYL-1,2-DIHYDRO-2-OXO-4-PYRIMIDINYL)DOCOSANAMIDE

NSC-239336

SUNRABIN

BEHENOYLCYTOSINE ARABINOSIDE

BH-AC

ENOCITABINE

CS-1807

1-benzimidazolyl-(5-bromo-2-furanyl)methanone

n-(1-beta-d-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-docosanamid

n(sup4)-behenoyl-1-beta-d-arabinofuranosylcytosine

n(sup4)-behenoylcytosinearabinoside

N-[1-[(2R,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-pyrimidin-4-yl]docosanamide

1-β-D-Arabinofuranosyl-4-(1-oxodocosyl)amino-1,2-dihydropyrimidin-2-one

Enocitabine API

N-(1-B-D-Arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)docosanamide, Behenoylcytosine Arabinoside, BH-AC, NSC-239336, Sunrabin

Docosanamide, N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-

N4-Behenoyl-1-β-D-arabinofuranosylcytosine

N4-Behenoylcytosine arabinoside

N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide

ENOCITABINE 98.5+% ANTINEOPLASTIC DRUGS

N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide Enocitabine

N(4)-behenoyl-1-beta-arabinofuranosylcytosine

N-(1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)docosanamide

Inhibitor,CMV,Enocitabine,inhibit,DNA/RNA Synthesis,Sunrabin,Cytomegalovirus,AML,acute myelogenous leukaemia,Nucleoside Antimetabolite/Analog

55726-47-1

C31H55N3O6

Intermediates & Fine Chemicals

Pharmaceuticals